Biologicals: characteristics that make them unique and special

2016-11-25 The unique characteristics of biologicals were discussed in a review of biosimilars in rheumatology by author José M Serra López-Matencio and colleagues from the Universidad… Read More »

Impact of South Korea’s new drug–pricing policy on market competition

2016-11-23 In April 2012, the Korean Government implemented a new policy to try and make its multiple sourced (off-patent) market more competitive. Their objective was to… Read More »

How the biosimilars market is changing

2016-11-21 Access to high quality medicine at affordable prices without jeopardizing patients’ health is one of the key challenges in developed countries where rising life expectancy… Read More »

IPRF template for summary information for biosimilar reviews

2016-11-18 The Biosimilars Working Group (BWG) of the International Pharmaceutical Regulators Forum (IPRF) has released a template for Public Assessment Summary Information for Biosimilar (PASIB). The… Read More »

Epoetin alfa biosimilar effective in treating anaemia

2016-11-16 Authors of a post-marketing study of the epoetin alfa biosimilar Retacrit say that the biosimilar is effective and well tolerated in treating chemotherapy-induced anaemia (CIA)… Read More »

Impact of breast cancer generics in Europe

2016-11-14 Breast cancer generics can increase patient adherence and reduce healthcare budgets for European countries, according to a report by the Germany-based Institute for Healthcare and… Read More »

Biosimilars: a new challenge in the current pharmacology

2016-11-11 In a review of biosimilars in rheumatology author José M Serra López-Matencio and colleagues from the Universidad Autónoma, Madrid, Spain discuss issues surrounding biosimilars*. The… Read More »

Costs and prices of entecavir to treat Hepatitis B

2016-11-09 In an analysis of the costs and target prices of Hepatitis B treatment entecavir, author Andrew Hill from Liverpool University, UK and colleagues from Imperial… Read More »

Pharmacovigilance for mAbs

2016-11-07 Professor Pierre Michetti, a gastroenterologist at the Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland in his paper discusses questions related to monoclonal antibody (mAb) biosimilars [1].… Read More »

US doctors poised to prescribe biosimilars

2016-11-04 A survey of specialists in the US has found that nearly half of them expect to prescribe biosimilars to treatment-naïve patients. The survey by healthcare… Read More »

Page 3 of 48 « Previous1 2 3 4 5 Next »... 48
Go Back Print